Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction

Fig. 5

Performances of POSTN in diagnosis of CA153 or CEA-negative BCa patients ROC curves of POSTN as individual markers to distinguish CA153-negative (A, n = 112) or CEA-negative (B, n = 134) BCa patients from healthy controls (n = 69), respectively. The corresponding subgroups were all indicated above the corresponding ROC curves

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us